SCHEMBL17949048

SCHEMBL17949048

CSc1ccc(-c2sc(CN)nc2C(=O)O)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 1/20 0.37
▸ HAO1 Q9UJM8 1/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PLAU P00749 1/20 0.36
▸ ADORA3 P0DMS8 4/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ STK17B O94768 1/20 0.36
▸ MAP3K8 P41279 1/20 0.36
▸ STK17A Q9UEE5 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17948781 0.81 PTPRC (0.42) ALDH1A1HSD17B10CYP1A2CYP2C9KDM4E
SCHEMBL17948786 0.81 KDM4E (0.53) ALDH1A1KDM4EHPGDPKMPPARD
SCHEMBL17949063 0.78 SLC22A12 (0.39) ALDH1A1HSD17B10STK17BMAP3K8CYP1A2
SCHEMBL17941780 0.75 MEN1 (0.37) HAO1L3MBTL1NPC1TDP1ADORA3
SCHEMBL19762720 0.74 L3MBTL1 (0.48) HAO1L3MBTL1NPC1TDP1ADORA3
SCHEMBL17949008 0.70 HAO1 (0.37) HAO1PLAUADORA3ADORA2AADORA2B
SCHEMBL27789562 0.69 KDM4E (0.47) NPC1ALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL1258223 0.69 MAPK14 (0.45) ALDH1A1HSD17B10CYP1A2CYP2C9
SCHEMBL20376593 0.69 KDM4E (0.44) ALDH1A1HSD17B10CYP1A2CYP2C9KDM4E
SCHEMBL13398494 0.68 KDM4E (0.46) ALDH1A1HSD17B10CYP1A2CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230046194-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-02-16 — — US disclosed
US-20200370057-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-11-26 — — US disclosed
US-10745705-B2 Ribosome-mediated incorporation of peptides and peptidomimetics ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-08-18 — — US disclosed
US-20180002709-A1 RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-01-04 — — US disclosed
WO-2016118877-A1 RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2016-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002709-A1 RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS NPEPPS, DNPEP, AARS1 FBP1 2441/4885HAO1 4542/4885L3MBTL1 778/4885
US-20200370057-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics NPEPPS, DNPEP, AARS1 FBP1 2441/4885HAO1 4542/4885L3MBTL1 778/4885
US-20230046194-A1 Ribosome-Mediated Incorporation of Peptides and Peptidomimetics NPEPPS, DNPEP, AARS1 FBP1 2441/4885HAO1 4542/4885L3MBTL1 778/4885
US-10745705-B2 Ribosome-mediated incorporation of peptides and peptidomimetics NPEPPS, DNPEP, AARS1 FBP1 2441/4885HAO1 4542/4885L3MBTL1 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback